CRISPR Therapeutics AG Balance Sheet

Balance Sheet Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Assets 159.42M344.96M271.35M489.02M1066.75M1827.97M2751.88M2243.06M2229.57M2242.03M
Current Assets
Cash & Equivalents 155.96M318.67M239.76M456.65M943.77M1168.62M923.03M211.88M389.50M298.26M
Short-term Investments 521.71M1456.10M1603.43M1304.21M1605.57M
Cash & Current Investments 155.96M318.67M239.76M456.65M943.77M1690.33M2379.13M1815.32M1693.71M1903.83M
Receivables - Net 0.34M3.16M2.63M0.09M0.10M0.14M0.30M200.00M25.00M
Receivables - Other 0.75M0.82M0.09M25.70M10.70M8.40M11.20M6.50M2.10M
Receivables 0.34M3.91M3.45M0.18M25.80M10.84M8.71M206.50M27.10M
Prepaid Assets 0.54M1.51M6.00M9.66M43.68M26.14M38.08M37.71M14.39M8.31M
Current Assets 156.84M320.19M248.38M466.39M987.55M1716.62M2417.51M1853.03M1908.08M1937.13M
Non-Current Assets
Property, Plant & Equipment (Net) 1.33M21.03M18.86M18.50M31.33M42.16M137.57M163.63M151.94M134.09M
Long-Term Investments 53.13M2.00M
Intangibles 0.45M0.40M0.34M0.29M0.23M0.18M0.12M0.07M0.02M
Goodwill & Intangibles 0.45M0.40M0.34M0.29M0.23M0.18M0.12M0.07M0.02M
Other Non-Current Assets 0.70M3.15M3.15M3.16M5.04M16.85M16.91M11.63M11.59M15.83M
Non-Current Assets 2.58M24.77M22.96M22.62M79.20M111.35M334.36M390.03M321.49M304.90M
Liabilities
Current Liabilities
Accounts Payables 1.58M4.57M1.64M5.07M5.94M9.09M14.82M27.43M38.15M14.71M
Payables 1.58M4.57M1.64M5.07M5.94M9.09M14.82M27.43M38.15M14.71M
Accumulated Expenses 8.43M16.32M11.36M20.85M30.18M53.78M91.00M77.68M45.34M41.07M
Other Accumulated Expenses 0.69M1.08M0.24M0.60M10.95M7.21M1.26M1.16M5.14M10.42M
Current Leases 8.49M11.36M12.16M15.84M15.62M17.29M
Current Taxes 0.08M0.02M0.35M0.40M0.58M10.47M0.72M0.14M0.44M0.45M
Current Deferred Revenue 1.03M1.03M1.20M12.70M12.20M12.30M12.30M12.30M3.85M
Total Current Liabilities 10.15M22.00M14.51M27.75M57.11M94.26M119.88M121.11M108.79M87.78M
Non-Current Liabilities
Convertible Debt 38.34M
Non-Current Deffered Revenue 75.09M77.65M56.93M57.78M11.78M11.78M12.32M12.32M14.01M12.32M
Preferred Stock Liabilities 30.44M
Minority Interest -0.03M
Operating Leases 44.05M50.07M212.87M228.18M223.01M206.41M
Other Non-Current Liabilities 0.28M0.19M0.31M0.24M14.39M7.63M7.34M5.97M0.96M3.44M
Total Non-Current Liabilities 123.75M111.93M83.20M96.58M112.93M156.10M345.08M361.61M345.81M306.51M
Liabilities
Total Liabilities 124.03M112.12M83.51M96.82M127.33M163.73M352.42M367.58M346.77M309.95M
Shareholder's Equity
Common Equity -29.12M232.85M187.83M392.19M939.42M1664.23M2399.46M1875.48M1882.80M1932.08M
Shareholder's Equity -29.12M232.85M187.83M392.19M939.42M1664.23M2399.46M1875.48M1882.80M1932.08M
Liabilities and Shareholders Equity 159.42M344.96M271.35M489.02M1066.75M1827.97M2751.88M2243.06M2229.57M2242.03M
Treasury Shares -0.44M0.44M-0.06M0.25M0.20M0.18M0.18M0.17M0.17M
Retained Earnings -33.91M-57.08M-125.44M-291.57M-224.71M-573.58M-195.91M-846.09M-999.70M-1365.95M